title: New targets for cancer chemotherapy.
authors.affiliation: Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Boulevard, Room 715, Rockville, MD 20852, USA.
authors.forename: S G
authors.initials: SG
authors.lastname: Arbuck
authors.forename: J
authors.initials: J
authors.lastname: Dancey
authors.forename: J M
authors.initials: JM
authors.lastname: Pluda
authors.forename: L
authors.initials: L
authors.lastname: Grochow
authors.forename: A J
authors.initials: AJ
authors.lastname: Murgo
authors.forename: P
authors.initials: P
authors.lastname: Ivy
authors.forename: J
authors.initials: J
authors.lastname: Wright
authors.forename: B
authors.initials: B
authors.lastname: Blaylock
authors.forename: L E
authors.initials: LE
authors.lastname: Via
authors.forename: E A
authors.initials: EA
authors.lastname: Sausville
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002453:Cell Cycle / Q000187:drug effects; D018797:Cell Cycle Proteins / Q000037:antagonists & inhibitors*; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology
chemical_list: D000970:Antineoplastic Agents; D018797:Cell Cycle Proteins; D004791:Enzyme Inhibitors